ABIONYX PHARMA: cashflow_investing
| Value | {"amount": -76000.0, "concept": "ifrs-full:CashFlowsFromUsedInInvestingActivities"} |
|---|---|
| Period | 2024-01-01 – 2024-12-31 |
| Status | current |
| Entity | ABIONYX PHARMA |
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
Retrieved: 2026-08-23T22:42:18.659153+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/f7479c6f-c3fa-45f5-a025-e8c57b52ae8d
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
esef:969500785J7VIC5YPC96:2025-12-31Retrieved: 2026-08-23T22:42:18.659153+02:00
Raw response sha256:
df7f82c289c957874561346a37c93090…Cite as: FACTANKER, https://factanker.com/fact/f7479c6f-c3fa-45f5-a025-e8c57b52ae8d
History
- no predecessors — first report